Multiple Myeloma

This Cancer Drug Candidate Could Be a Hit for Pfizer
Motley Fool
Sun, 03/26/23 - 11:19 pm
Pfizer
elranatamab
Multiple Myeloma
Bristol Myers details landmark Abecma multiple myeloma data that ASH turned down
Fierce Pharma
Sun, 02/12/23 - 07:46 pm
Bristol Myers Squibb
Abecma
CAR-T
Multiple Myeloma
J&J, Legend’s cancer cell therapy has early success in key clinical trial
BioPharma Dive
Mon, 01/30/23 - 10:27 am
JNJ
Legend Biotech
Carvykti
Multiple Myeloma
clinical trials
cell therapy
Sales of J&J, Legend cell therapy plateau amid production challenges
BioPharma Dive
Wed, 01/25/23 - 10:57 pm
JNJ
Legend Biotech
gene therapy
Carvykti
Multiple Myeloma
ASH: Bristol's 3rd-line Abecma data didn't make the trip to New Orleans. Is it cause for concern?
Fierce Pharma
Mon, 12/12/22 - 10:59 pm
Bristol Myers Squibb
ASH 2022
Abecma
clinical trials
Multiple Myeloma
J&J’s next myeloma drug, Argenx’s second act and a new question for Bluebird: 3 ASH takeaways
BioPharma Dive
Mon, 12/12/22 - 10:56 pm
ASH 2022
JNJ
talquetamab
Multiple Myeloma
Argenx
Bluebird Bio
Vyvgart
ITP
ASH: In next BCMA myeloma race, Gracell dazzles with 100% response rate as Pfizer, BMS place their bets
Fierce Biotech
Mon, 12/12/22 - 10:33 am
ASH 2022
Gracell
CAR-T
Multiple Myeloma
Bristol Myers Squibb
Pfizer
Gilead lands new cell therapy for Kite in $225M Arcellx deal
Fierce Biotech
Fri, 12/9/22 - 10:37 am
Gilead Sciences
Kite Pharma
Arcellx
clinical trials
Multiple Myeloma
cell therapy
JNJ
Legend Biotech
FDA looks to pull approval for Oncopeptides' troubled multiple myeloma drug Pepaxto
Fierce Pharma
Thu, 12/8/22 - 10:01 am
Oncopeptides
Multiple Myeloma
Pepaxto
FDA
GSK to pull blood cancer drug from US market after study failure
BioPharma Dive
Tue, 11/22/22 - 11:08 am
GSK
blood cancer
Blenrep
clinical trials
Multiple Myeloma
Time for GSK to stop dreaming about Blenrep
EP Vantage
Mon, 11/7/22 - 10:53 am
GSK
BCMA
Blenrep
clinical trials
Multiple Myeloma
J&J nabs FDA okay for BCMA bispecific Tecvayli
Pharmaphorum
Wed, 10/26/22 - 07:00 pm
JNJ
Multiple Myeloma
Tecvayli
FDA
FDA advisory committee issues back to back negative votes on two cancer drugs
MedCity News
Mon, 09/26/22 - 10:31 am
FDA
Spectrum Pharmaceuticals
Oncopeptides
clinical trials
poziotinib
Pepaxto
Multiple Myeloma
Despite being approved in Europe, Oncopeptides' Pepaxto will remain sidelined in the US
Fierce Pharma
Sun, 09/25/22 - 02:00 pm
FDA
Oncopeptides
Multiple Myeloma
Pepaxto
Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma
Clinical Trials Arena
Mon, 08/29/22 - 10:32 am
JNJ
Janssen
clinical trials
Darzalex
Revlimid
Velcade
Multiple Myeloma
J&J bags first nod for multiple myeloma bispecific to complement its own CAR-T offering
Fierce Pharma
Thu, 08/25/22 - 07:43 pm
JNJ
Europe
bispecific antibodies
Multiple Myeloma
Tecvayli
teclistamab
Bristol Myers claims success in study testing earlier CAR-T use in multiple myeloma
BioPharma Dive
Wed, 08/10/22 - 11:34 pm
Bristol Myers Squibb
2seventy bio
Abecma
CAR-T
Multiple Myeloma
Amgen takes BiTEs out of pipeline, dropping BCMA, PSMA assets in light of data and competition
Fierce Biotech
Fri, 08/5/22 - 10:42 am
Amgen
BCMA
PSMA
Multiple Myeloma
bispecific antibodies
Janssen secures FDA breakthrough designation for myeloma therapy
Pharmaceutical Business Review
Thu, 06/30/22 - 10:54 am
JNJ
Janssen
breakthrough therapy
FDA
talquetamab
Multiple Myeloma
relapsed or refractory multiple myeloma
ASCO 2022 – Carvykti casts a long shadow
EP Vantage
Mon, 06/6/22 - 10:01 am
ASCO 2022
Carvykti
CAR-T
Arcellx
Gracell
Oricell
Multiple Myeloma

Pages